Live Breaking News & Updates on Prior Sales Agreement

Stay updated with breaking news from Prior sales agreement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lineage Cell Therapeutics : Immediate Report -March 24, 2024 at 04:37 am EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
. ....

New York , United States , City Of New York , Georgea Samuel , Subsidiary Of The Company , Commission File Number , Lineage Cell Therapeutics Inc , Exchange Commission The , Governmental Authority , B Riley Securities Inc , Cantor Fitzgerald Co , Company The Prospectus , Exchange Commission , Warranties Of The Company , Placement Shares Of The Company , Company Or Lineage , Financial Industry Regulatory Authority Inc , Public Company Accounting Oversight Board United States , United States Drug Enforcement Administration , Securities Exchange , Termination Of Prior Offering Program , Consent Of Sheppard Mullin Richter Hampton , Opinion Of Sheppard Mullin Richter Hampton , Neither The Company , Sales Of The Company , Drug Administration ,

Inventiva : Information Contained in this Report - Form 6-K -September 29, 2023 at 10:49 am EDT

Information Contained in this Report

On September 28, 2023, Inventiva S.A. entered into a Sales Agreement with Cowen and Company, LLC with respect to an equity offering. ....

Gide Loyrette Nouel , Securities Exchange , Sales Of The Company Adss , Company Llc Td Cowen , Company French , Information Contained , Sales Agreement , American Depositary Shares , Registration Statement , Securities Act , Securities Exchange Act , Prior Sales Agreement , Prior Sales ,

IOVANCE BIOTHERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)

Item 1.01. Entry Into a Material Definitive Agreement.

On June 16, 2023, Iovance Biotherapeutics, Inc. entered into a
new Open Market Sale Agreement with Jefferies LLC
with respect to an at the. | June 16, 2023 ....

Securities Exchange , Iovance Biotherapeutics Inc , Exchange Commission , Material Definitive , Open Market Sale Agreement , Prior Sales Agreement , Sales Agreement , Prior Sales , Common Shares , Securities Act , Securities Exchange Act , Current Report , Market Sale Agreement , Page Interactive Data File , Interactive Date File , Edgar Online , Iovance Biotherapeutics , Nc Stock Exchange , Press Release , T Iova Us4622601007 ,

SYNDAX PHARMACEUTICALS INC : Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)

Item 1.02 Termination of a Material Definitive Agreement.

As previously disclosed, on March 22, 2021, Syndax Pharmaceuticals, Inc.
entered into a sales agreement with
Cowen and Company, LLC ,. | May 26, 2023 ....

Syndax Pharmaceuticals Inc , Company Llc Td Cowen , Material Definitive , Prior Sales Agreement , Placement Shares , Registration Statement , Current Report , New Sales Agreement , Securities Act , Nasdaq Global Select Market , Placement Notice , New Sales , Page Interactive Data File , Edgar Online , Syndax Pharmaceuticals , Nc Stock Exchange , Press Release , Lc Sndx Us87164f1057 ,

You should read the following discussion and analysis of our financial condition
and results of operations together with our Unaudited Condensed Consolidated
Financial Statements and related notes. | May 4, 2023 ....

United States , American Society Of Clinical Oncology , American Society Of Hematology , European Hematology Association Congress , Silicon Valley Bank , Jjdc Inc , Protagonist Therapeutics Inc , Exchange Commission , Deposit Insurance Corporation , Janssen Biotech Inc , Development Expenses , Federal Reserve , Securities Exchange , Audited Consolidated Financial Statements , Annual Report , Quarterly Report , Securities Act , Securities Exchange Act , Product Pipeline , Clinical Oncology , Annual Meeting , Hematology Association Congress , Inflation Reduction Act , Psoriasis Area , Severity Index , Valley Bank ,